Treatment of Hypertension in Coarctation of the Aorta

被引：17

作者：

Nakamura K. ^{[1
]}

Stefanescu Schmidt A. ^{[1
]}

机构：

[1] Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Yawkey 5B, Boston, 02114, MA

来源：

Current Treatment Options in Cardiovascular Medicine | 2016年 / 18卷 / 6期

基金：

美国国家卫生研究院;

关键词：

Aorta; Coarctation; Congenital heart disease; Hypertension;

D O I：

10.1007/s11936-016-0462-x

中图分类号：

学科分类号：

摘要：

The treatment of hypertension in coarctation of the aorta (CoA) is ideally managed by early surgical or transcatheter repair to reduce the risk of irreversible aortopathy and refractory hypertension, in addition to other associated sequelae including premature coronary artery disease; stroke; aortic aneurysm, dissection, and rupture; infective endocarditis; and heart failure. The choice of surgical or transcatheter repair is dependent on individual patient considerations. Medical therapy for hypertension due to CoA parallels treatment of essential hypertension with beta blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers as first-line agents. © 2016, Springer Science+Business Media New York.

引用

共 28 条

[1]

Bernier P.L., Stefanescu A., Samoukovic G., Tchervenkov C.I., The challenge of congenital heart disease worldwide: epidemiologic and demographic facts, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, 13, 1, pp. 26-34, (2010)

[2]

Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Blaha M.J., Et al., Heart disease and stroke statistics—2014 update: a report from the American Heart Association, Circulation, 129, 3, pp. e28-e292, (2014)

[3]

Kaemmerer H., Aortic coarctation and interrupted aortic arch, Diagnosis and management of adult congenital heart disease, pp. 261-270, (2011)

[4]

Lee M.G., Allen S.L., Kawasaki R., Kotevski A., Koleff J., Kowalski R., Et al., High prevalence of hypertension and end-organ damage late after coarctation repair in normal arches, Ann Thorac Surg, 100, 2, pp. 647-653, (2015)

[5]

Wilson P.D., Loffredo C.A., Correa-Villasenor A., Ferencz C., Attributable fraction for cardiac malformations, Am J Epidemiol, 148, 5, pp. 414-423, (1998)

[6]

Sybert V.P., Cardiovascular malformations and complications in Turner syndrome, Pediatrics, 101, 1, (1998)

[7]

Carlson M., Airhart N., Lopez L., Silberbach M., Moderate aortic enlargement and bicuspid aortic valve are associated with aortic dissection in Turner syndrome: report of the international turner syndrome aortic dissection registry, Circulation, 126, 18, pp. 2220-2226, (2012)

[8]

Warnes C.A., Williams R.G., Bashore T.M., Child J.S., Connolly H.M., Dearani J.A., Et al., ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease), Circulation, 118, 23, pp. e714-e833, (2008)

[9]

Cohen J.R., Birnbaum E., Coarctation of the abdominal aorta, J Vasc Surg, 8, 2, pp. 160-164, (1988)

[10]

Shone J.D., Sellers R.D., Anderson R.C., Adams P., Lillehei C.W., Edwards J.E., The developmental complex of “parachute mitral valve,” supravalvular ring of left atrium, subaortic stenosis, and coarctation of aorta, Am J Cardiol, 11, pp. 714-725, (1963)

← 1 2 3 →